Figure 4From: Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinomaScores of p501s and PSA expression in metastatic prostatic lesions (A) and percentage of cases negative for p501s and PSA stains (B). MLN: metastatic prostatic carcinoma to lymph nodes. MC: metastatic prostatic carcinoma to other sites.Back to article page